Forte Biosciences Statistics Share Statistics Forte Biosciences has 12.21M
shares outstanding. The number of shares has increased by 350.87%
in one year.
Shares Outstanding 12.21M Shares Change (YoY) 350.87% Shares Change (QoQ) 2.97% Owned by Institutions (%) 44.17% Shares Floating 10.58M Failed to Deliver (FTD) Shares 3,033 FTD / Avg. Volume 2.9%
Short Selling Information The latest short interest is 128.75K, so 1.05% of the outstanding
shares have been sold short.
Short Interest 128.75K Short % of Shares Out 1.05% Short % of Float 1.25% Short Ratio (days to cover) 3.6
Valuation Ratios The PE ratio is -1.87 and the forward
PE ratio is -3.83.
Forte Biosciences's PEG ratio is
0.04.
PE Ratio -1.87 Forward PE -3.83 PS Ratio 0 Forward PS 16 PB Ratio 1.26 P/FCF Ratio -2.15 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Forte Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.76,
with a Debt / Equity ratio of 0.
Current Ratio 6.76 Quick Ratio 6.76 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.53M Employee Count 14 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 42.03% in the
last 52 weeks. The beta is 2.91, so Forte Biosciences's
price volatility has been higher than the market average.
Beta 2.91 52-Week Price Change 42.03% 50-Day Moving Average 11.42 200-Day Moving Average 11.46 Relative Strength Index (RSI) 58.7 Average Volume (20 Days) 104,474
Income Statement
Revenue n/a Gross Profit -39K Operating Income -36.6M Net Income -35.48M EBITDA -35.44M EBIT -35.48M Earnings Per Share (EPS) -12.17
Full Income Statement Balance Sheet The company has 22.24M in cash and 0 in
debt, giving a net cash position of 22.24M.
Cash & Cash Equivalents 22.24M Total Debt n/a Net Cash n/a Retained Earnings -154M Total Assets 107.78M Working Capital 98.45M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -30.75M
and capital expenditures -37K, giving a free cash flow of -30.78M.
Operating Cash Flow -30.75M Capital Expenditures -37K Free Cash Flow -30.78M FCF Per Share -10.56
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields FBRX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for FBRX is $68,
which is 478.2% higher than the current price. The consensus rating is "Buy".
Price Target $68 Price Target Difference 478.2% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 28, 2024. It was a
backward
split with a ratio of 1:25.
Last Split Date Aug 28, 2024 Split Type backward Split Ratio 1:25
Scores Altman Z-Score 6.8 Piotroski F-Score 3
